CANbridge Pharmaceuticals Inc. (1228.HK) HKSE

2.82

-0.06(-2.08%)

Updated at September 09 01:41PM

Currency In HKD

Valuation

Market Cap53.07M
Enterprise Value178.34M
P/E Ratio-2.53
PEG Ratio0.63
Price/Sales Ratio13.15
Price/Book Ratio-2.36
Enterprise/Revenue14.62
Enterprise/EBITDA-3.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-5.2
Operating Margin-4

Management Effectiveness

Return On Assets-3.79
Return On Equity1.17

Income Statement

Revenue85.1M
Revenue/Share0.2
Gross Profit54.3M
EBITDA-328.69M
Net Income-442.62M
Diluted EPS-1.04

Balance Sheet

Total Cash10.5M
Total Cash/Share0.02
Total Debt135.78M
Total Debt/Equity-0.29
Current Ratio0.09
Book Value Per Share-1.12

Price History

52-Week Change800
52-Week High2.92
52-Week Low0.1
Moving Average 50 Days1.31
Moving Average 200 Days0.45

Statistics

Average Volume14.97M
Shares Outstanding424.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A